307
Views
11
CrossRef citations to date
0
Altmetric
Drug profile

Volanesorsen for treatment of familial chylomicronemia syndrome

ORCID Icon & ORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Catherine M Spagnuolo & Robert A Hegele. (2023) Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors. Expert Opinion on Pharmacotherapy 24:9, pages 1013-1020.
Read now
Isabel Shamsudeen & Robert A. Hegele. (2022) Safety and efficacy of therapies for chylomicronemia. Expert Review of Clinical Pharmacology 15:4, pages 395-405.
Read now

Articles from other publishers (9)

Yongshu Li, Bihui Huang, Zhichao Xue, Yunhua Gao & Zhenjian Zhuo. (2022) Nucleic acid therapy in pediatric cancer. Pharmacological Research 184, pages 106441.
Crossref
Daniel G. Hackam & Robert A. Hegele. (2022) Lipid-Modifying Therapies and Stroke Prevention. Current Neurology and Neuroscience Reports 22:7, pages 375-382.
Crossref
Ioanna Gouni-Berthold & Jonas Schwarz. (2022) New therapeutic approaches for the treatment of hypertriglyceridemiaNeue Therapieansätze für Hypertriglyzeridämie. Herz 47:3, pages 220-227.
Crossref
Bai-Hui Zhang, Fan Yin, Ya-Nan Qiao & Shou-Dong Guo. (2022) Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis. Frontiers in Molecular Biosciences 9.
Crossref
Yonglang Cheng, Tongxi Li, Peng Tan, Yichao Du, Zhiwei Huang, Hao Shi, Tianying Cai, Yifan Chen & Wenguang Fu. (2022) Efficacy and safety of the apolipoprotein C-III inhibitor Volanesorsen: a systematic evaluation and meta-analysis. Endocrine 76:2, pages 253-262.
Crossref
Carlos A Aguilar-Salinas, Rita A Gómez-Díaz & Pablo Corral. (2022) New Therapies for Primary Hyperlipidemia. The Journal of Clinical Endocrinology & Metabolism 107:5, pages 1216-1224.
Crossref
Robert A. Hegele. (2022) Apolipoprotein C-III inhibition to lower triglycerides: one ring to rule them all?. European Heart Journal 43:14, pages 1413-1415.
Crossref
Isabel Shamsudeen & Robert A. Hegele. (2022) Advances in the care of lipodystrophies. Current Opinion in Endocrinology, Diabetes & Obesity 29:2, pages 152-160.
Crossref
Gary F Lewis & Robert A Hegele. (2022) Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia. The Lancet Diabetes & Endocrinology 10:2, pages 142-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.